Educational research on US and Indian equities, ETFs, mutual funds and crypto, with screeners and a free investing academy.
All data is for educational purposes only and should not be considered investment advice.
Equiscale is operated by Syntellia LLC, a Delaware limited liability company.
© 2026 Syntellia LLC. All rights reserved.
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company was founded in 1980 and is headquartered in Long Beach, California.
Rule-based from financial data. Not advice.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 5 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $45.4B | - | $472M | $-636M | 11.6% | 11.7% | -60.0% |
| 2024 | $40.6B | - | $1.2B | $544M | 26.2% | 19.3% | 8.1% |
| 2023 | $34.1B | - | $1.1B | $1.6B | 25.9% | 6.6% | 37.8% |
| 2022 | $32.0B | - | $792M | $682M | 26.7% | - | - |
| 2021 | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2025 |
|---|---|
| Total Revenue | 45,426 |
| Operating Revenue | 43,052 |
| Cost Of Revenue | 41,351 |
| Gross Profit | 4,075 |
| Operating Expense | 3,294 |
| Selling General And Administration | 3,009 |
| Total Expenses | 44,645 |
| Operating Income | 781 |
| Total Operating Income As Reported | 781 |
| Normalized EBITDA | 976 |
| EBIT | 781 |
| Interest Expense | 192 |
| Net Interest Income | -192 |
| Other Non Operating Income Expenses | - |
| Other Income Expense | - |
| Interest Expense Non Operating | 192 |
| Net Non Operating Interest Income Expense | -192 |
| Pretax Income | 589 |
| Tax Provision | 117 |
| Tax Rate For Calcs | 0 |
| Tax Effect Of Unusual Items | 0 |
| Net Income Continuous Operations | 472 |
| Net Income From Continuing And Discontinued Operation | 472 |
| Net Income From Continuing Operation Net Minority Interest | 472 |
| Net Income | 472 |
| Net Income Common Stockholders | 472 |
| Net Income Including Noncontrolling Interests | 472 |
| Normalized Income | 472 |
| Diluted NI Availto Com Stockholders | 472 |
| Basic Average Shares | 51.40 |
| Diluted Average Shares | 52.90 |
| Reconciled Depreciation | 195 |
| Reconciled Cost Of Revenue | 41,351 |
| Total Unusual Items | - |
| Total Unusual Items Excluding Goodwill | - |
| Special Income Charges | - |
| Write Off | - |
| Impairment Of Capital Assets | - |
| Depreciation Amortization Depletion Income Statement | 195 |
| Depreciation And Amortization In Income Statement | 195 |
| General And Administrative Expense | 3,009 |
| Other Gand A | 3,009 |
| Other Operating Expenses | 90 |
| Amortization | 91 |
| Amortization Of Intangibles Income Statement | 91 |
| Depreciation Income Statement | 104 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Molina Healthcare, Inc.this co. | MOH | $10.0B | 21.28↓ discount | 2.47 | 11.6% | - |
| Revvity, Inc. | RVTY | $11.4B | 47.36 | 1.58 | 3.3% | 18.15 |
| BrightSpring Health Services, Inc. | BTSG | $11.3B | 59.39 | 6.04 | 10.2% | 30.34 |
| Baxter International Inc. | BAX | $10.0B | -10.44 | 1.63 | -15.6% | 23.25 |
| Krystal Biotech, Inc. | KRYS |
| - |
| - |
| - |
| - |
| - |
| $9.1B |
| 44.30 |
| 7.44 |
| 16.8% |
| 51.16 |
| Charles River Laboratories International, Inc. | CRL | $8.9B | - | 2.83 | -4.6% | 27.52 |
| Henry Schein, Inc. | HSIC | $8.7B | 21.84 | 2.68 | 12.3% | 12.42 |
| Bio-Techne Corporation | TECH | $8.3B | 113.50 | 4.34 | 3.8% | 39.69 |
| Corcept Therapeutics Incorporated | CORT | $8.0B | 80.68 | 12.41 | 15.4% | 66.11 |
| Peer Median | - | 47.36 | 3.58 | 7.0% | 28.93 | |